IL6 and metastatic neoplasm: Similar studies also demonstrated that IL-6, a downstream mediator of the IL-1β, induced expansion of MDSCs, and IL-1 receptor (IL-1R)-deficient mice have a delayed accumulation of MDSCs and delayed primary and metastatic tumor progression (22–24).